Recognition of SARS-CoV-2 peptides in the context of HLA class II molecules is essential for CD4+ T-cell activation and proliferation which, in turn, orchestrate the development of effector cellular (CD8+ T-cell) and humoral adaptive immune responses after viral infection and after vaccination. This evidence concerns the gene CD8A and viral infectious disease.